Goldman Sachs Group »

Terns Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $556k 86k 6.49
2023-09-30 $1.3M 259k 5.03
2023-06-30 $506k 58k 8.75
2023-03-31 $1.1M 89k 11.84
2022-12-31 $110k 11k 10.18
2022-06-30 $41k 17k 2.47
2022-03-31 $49k 16k 2.98
2021-12-31 $108k 15k 7.10